107 related articles for article (PubMed ID: 35021256)
1. Thrombotic Risk Determined by Protein C Receptor (PROCR) Variants among Middle-Aged and Older Adults: A Population-Based Cohort Study.
Manderstedt E; Halldén C; Lind-Halldén C; Elf J; Svensson PJ; Engström G; Melander O; Baras A; Lotta LA; Zöller B;
Thromb Haemost; 2022 Aug; 122(8):1326-1332. PubMed ID: 35021256
[TBL] [Abstract][Full Text] [Related]
2. Thrombomodulin (THBD) gene variants and thrombotic risk in a population-based cohort study.
Manderstedt E; Halldén C; Lind-Halldén C; Elf J; Svensson PJ; Engström G; Melander O; Baras A; Lotta LA; Zöller B;
J Thromb Haemost; 2022 Apr; 20(4):929-935. PubMed ID: 34970867
[TBL] [Abstract][Full Text] [Related]
3. Thrombotic risk determined by rare and common SERPINA1 variants in a population-based cohort study.
Manderstedt E; Halldén C; Lind-Halldén C; Elf J; Svensson PJ; Engström G; Melander O; Baras A; Lotta LA; Zöller B;
J Thromb Haemost; 2022 Jun; 20(6):1421-1427. PubMed ID: 35263815
[TBL] [Abstract][Full Text] [Related]
4. Genetic variation of the blood coagulation regulator tissue factor pathway inhibitor and venous thromboembolism among middle-aged and older adults: A population-based cohort study.
Manderstedt E; Lind-Halldén C; Halldén C; Elf J; Svensson PJ; Engström G; Melander O; Baras A; Lotta LA; Zöller B;
Res Pract Thromb Haemost; 2022 Oct; 6(7):e12842. PubMed ID: 36381289
[TBL] [Abstract][Full Text] [Related]
5. Classic Thrombophilias and Thrombotic Risk Among Middle-Aged and Older Adults: A Population-Based Cohort Study.
Manderstedt E; Lind-Halldén C; Halldén C; Elf J; Svensson PJ; Dahlbäck B; Engström G; Melander O; Baras A; Lotta LA; Zöller B;
J Am Heart Assoc; 2022 Feb; 11(4):e023018. PubMed ID: 35112923
[TBL] [Abstract][Full Text] [Related]
6. PROC, PROCR and PROS1 polymorphisms, plasma anticoagulant phenotypes, and risk of cardiovascular disease and mortality in older adults: the Cardiovascular Health Study.
Reiner AP; Carty CL; Jenny NS; Nievergelt C; Cushman M; Stearns-Kurosawa DJ; Kurosawa S; Kuller LH; Lange LA
J Thromb Haemost; 2008 Oct; 6(10):1625-32. PubMed ID: 18680534
[TBL] [Abstract][Full Text] [Related]
7. The endothelial protein C receptor (PROCR) Ser219Gly variant and risk of common thrombotic disorders: a HuGE review and meta-analysis of evidence from observational studies.
Dennis J; Johnson CY; Adediran AS; de Andrade M; Heit JA; Morange PE; Trégouët DA; Gagnon F
Blood; 2012 Mar; 119(10):2392-400. PubMed ID: 22251481
[TBL] [Abstract][Full Text] [Related]
8. The association between EPCR gene p.Ser219Gly polymorphism and venous thromboembolism risk: a case-control study, meta-analysis, and a reproducibility study.
Pituk D; Miklós T; Schlammadinger Á; Rázsó K; Bereczky Z
Front Cardiovasc Med; 2023; 10():1270093. PubMed ID: 38075960
[TBL] [Abstract][Full Text] [Related]
9. Targeted gene sequencing identifies variants in the protein C and endothelial protein C receptor genes in patients with unprovoked venous thromboembolism.
Wu C; Dwivedi DJ; Pepler L; Lysov Z; Waye J; Julian J; Desch K; Ginsburg D; Weitz JI; Kearon C; Liaw PC
Arterioscler Thromb Vasc Biol; 2013 Nov; 33(11):2674-81. PubMed ID: 24051141
[TBL] [Abstract][Full Text] [Related]
10. Elucidating mechanisms of genetic cross-disease associations at the PROCR vascular disease locus.
Stacey D; Chen L; Stanczyk PJ; Howson JMM; Mason AM; Burgess S; MacDonald S; Langdown J; McKinney H; Downes K; Farahi N; Peters JE; Basu S; Pankow JS; Tang W; Pankratz N; Sabater-Lleal M; de Vries PS; Smith NL; ; Gelinas AD; Schneider DJ; Janjic N; Samani NJ; Ye S; Summers C; Chilvers ER; Danesh J; Paul DS
Nat Commun; 2022 Mar; 13(1):1222. PubMed ID: 35264566
[TBL] [Abstract][Full Text] [Related]
11. Functional analysis of two haplotypes of the human endothelial protein C receptor gene.
Medina P; Navarro S; Bonet E; Martos L; Estellés A; Bertina RM; Vos HL; España F
Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):684-90. PubMed ID: 24436369
[TBL] [Abstract][Full Text] [Related]
12. Paternal endothelial protein C receptor 219Gly variant as a mild and limited risk factor for deep vein thrombosis during pregnancy.
Galanaud JP; Cochery-Nouvellon E; Alonso S; Chauleur C; Mercier E; Lissalde-Lavigne G; Fabbro-Peray P; Reny JL; Mares P; Dauzat M; Quere I; Gris JC
J Thromb Haemost; 2010 Apr; 8(4):707-13. PubMed ID: 20141580
[TBL] [Abstract][Full Text] [Related]
13. Next-Generation Sequencing of 17 Genes Associated with Venous Thromboembolism Reveals a Deficit of Non-Synonymous Variants in Procoagulant Genes.
Manderstedt E; Lind-Halldén C; Svensson P; Zöller B; Halldén C
Thromb Haemost; 2019 Sep; 119(9):1441-1450. PubMed ID: 31352677
[TBL] [Abstract][Full Text] [Related]
14. Burden of rare exome sequence variants in PROC gene is associated with venous thromboembolism: a population-based study.
Tang W; Stimson MR; Basu S; Heckbert SR; Cushman M; Pankow JS; Folsom AR; Pankratz N
J Thromb Haemost; 2020 Feb; 18(2):445-453. PubMed ID: 31680443
[TBL] [Abstract][Full Text] [Related]
15. Whole-exome sequencing identifies rare variants in STAB2 associated with venous thromboembolic disease.
Desch KC; Ozel AB; Halvorsen M; Jacobi PM; Golden K; Underwood M; Germain M; Tregouet DA; Reitsma PH; Kearon C; Mokry L; Richards JB; Williams F; Li JZ; Goldstein D; Ginsburg D
Blood; 2020 Jul; 136(5):533-541. PubMed ID: 32457982
[TBL] [Abstract][Full Text] [Related]
16. The H1 haplotype of the endothelial protein C receptor protects against arterial thrombosis in patients with antiphospholipid syndrome.
Plasín-Rodríguez MA; Rodríguez-Pintó I; Patricio P; Monteagudo J; Cervera R; Reverter JC; Espinosa G; Tàssies D
Thromb Res; 2018 Sep; 169():128-134. PubMed ID: 30048851
[TBL] [Abstract][Full Text] [Related]
17. Lack of association of soluble endothelial protein C receptor and PROCR 6936A/G polymorphism with the risk of venous thromboembolism in a prospective study.
Yamagishi K; Cushman M; Heckbert SR; Tsai MY; Folsom AR
Br J Haematol; 2009 Apr; 145(2):221-6. PubMed ID: 19222470
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of 65,734 individuals identifies TSPAN15 and SLC44A2 as two susceptibility loci for venous thromboembolism.
Germain M; Chasman DI; de Haan H; Tang W; Lindström S; Weng LC; de Andrade M; de Visser MC; Wiggins KL; Suchon P; Saut N; Smadja DM; Le Gal G; van Hylckama Vlieg A; Di Narzo A; Hao K; Nelson CP; Rocanin-Arjo A; Folkersen L; Monajemi R; Rose LM; Brody JA; Slagboom E; Aïssi D; Gagnon F; Deleuze JF; Deloukas P; Tzourio C; Dartigues JF; Berr C; Taylor KD; Civelek M; Eriksson P; ; Psaty BM; Houwing-Duitermaat J; Goodall AH; Cambien F; Kraft P; Amouyel P; Samani NJ; Basu S; Ridker PM; Rosendaal FR; Kabrhel C; Folsom AR; Heit J; Reitsma PH; Trégouët DA; Smith NL; Morange PE
Am J Hum Genet; 2015 Apr; 96(4):532-42. PubMed ID: 25772935
[TBL] [Abstract][Full Text] [Related]
19. Genome wide association study for plasma levels of natural anticoagulant inhibitors and protein C anticoagulant pathway: the MARTHA project.
Oudot-Mellakh T; Cohen W; Germain M; Saut N; Kallel C; Zelenika D; Lathrop M; Trégouët DA; Morange PE
Br J Haematol; 2012 Apr; 157(2):230-9. PubMed ID: 22443383
[TBL] [Abstract][Full Text] [Related]
20. Association of the endothelial protein C receptor (PROCR) rs867186-G allele with protection from severe malaria.
Naka I; Patarapotikul J; Hananantachai H; Imai H; Ohashi J
Malar J; 2014 Mar; 13():105. PubMed ID: 24635948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
